The Flowr Corp FLWPF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- — / —
- Market Cap
- $42,646.86
- Volume/Avg
- 1,232 / 180,699
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
The Flowr Corp is a Toronto-headquartered cannabis company with operations in Canada and Europe. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a R&D facility that is awaiting licensing from Health Canada. From this campus, Flowr produces recreational and medicinal products. Internationally, it intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in Portugal.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 186
- Website
- https://www.flowr.ca
Valuation
|
Metric
|
FLWPF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
FLWPF
|
|---|---|
Quick Ratio | 0.87 |
Current Ratio | 1.40 |
Interest Coverage | −48.77 |
Quick Ratio
FLWPF
Profitability
|
Metric
|
FLWPF
|
|---|---|
Return on Assets (Normalized) | −30.88% |
Return on Equity (Normalized) | −107.39% |
Return on Invested Capital (Normalized) | −32.39% |
Return on Assets
FLWPF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| Llxwxtdj | Snbbhxh | $79.7 Bil | |||
| Zoetis Inc Class A
ZTS
| Vcmsmgczf | Mqfm | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Dfgvmqpj | Jlbn | $37.4 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Tttgpxfj | Ryrgm | $18.2 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Fqzmslzx | Pbwd | $12.1 Bil | |||
| Viatris Inc
VTRS
| Wygqxfx | Szwq | $12.0 Bil | |||
| Catalent Inc
CTLT
| Scmprjhk | Sdfzjb | $10.0 Bil | |||
| Perrigo Co PLC
PRGO
| Qvcthdcd | Rkqs | $3.6 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Dzftcqdm | Lpdzpfv | $3.2 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Lljlffyw | Jbbr | $3.0 Bil |